David Alonso‐Escolano

Nanoparticle‐induced platelet aggregation and vascular thrombosis

Anna Radomski, Paul Jurasz, David Alonso‐Escolano et al. · British Journal of Pharmacology · 2005 · 625 citations · Full text

Nanoparticles, Thrombosis, Nanomedicine +14

Membrane type‐1 matrix metalloproteinase stimulates tumour cell‐induced platelet aggregation: role of receptor glycoproteins

David Alonso‐Escolano, Alex Y. Strongin, Ada W.Y. Chung et al. · British Journal of Pharmacology · 2004 · 123 citations · Full text

The Nonthiazolidinedione PPARγ Agonist L-796,449 Is Neuroprotective in Experimental Stroke

Marta P. Pereira, Olivia Hurtado, Antonio Cárdenas et al. · Journal of Neuropathology & Experimental Neurology · 2005 · 75 citations · Full text

Cerebrovascular Disease, Pharmacotherapy, Cerebral Vascular Regulation +22

Cost-Effectiveness Analysis of Switching Antipsychotic Medication to Long-Acting Injectable Risperidone in Patients with Schizophrenia

J.M. Olivares, Alfonso Rodríguez-Martínez, José A. Burón et al. · Applied Health Economics and Health Policy · 2008 · 65 citations

Cost-effectiveness Analysis, Psychiatry, Switching Antipsychotic Medication +8

Platelet–leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases

Ada W.Y. Chung, Anna Radomski, David Alonso‐Escolano et al. · British Journal of Pharmacology · 2004 · 53 citations · Full text

Nitric Oxide, Immunology, Inflammation +16